What Is N-Acetyl Selank Amidate?
N-Acetyl Selank Amidate is a chemically modified analog of the Russian anxiolytic nootropic peptide Selank, engineered with an N-terminal acetyl group and a C-terminal amide to resist enzymatic breakdown. These end-cap modifications are a standard way to slow peptide degradation, and vendors market the result as a longer-lasting, “more potent” version of Selank aimed at anxiety and focus. It is sold as a research chemical, not as an approved drug or dietary supplement anywhere.
Evidence
There is essentially no independent, peer-reviewed clinical or animal literature on N-Acetyl Selank Amidate specifically. Almost all information about it comes from peptide vendors and nootropic communities rather than verifiable trials — I did not find a citable PubMed study on this exact compound in this pass. The underlying chemistry claim (that N-acetylation plus C-terminal amidation increases resistance to peptidases and can extend half-life) is a well-established structure–activity principle, but that is broad framing, not evidence that this analog is safe or more effective than Selank in humans. The “more potent than Selank” claim is at present an extrapolation, not a demonstrated finding. For the parent peptide’s (largely Russian, harder-to-verify) evidence, see the Selank page.
Dosage & Safety
N-Acetyl Selank Amidate is an unapproved research chemical — not a medicine and not a dietary supplement — and this section is informational only, not a recommendation to use it. No reliable studied human dose range exists; figures circulated online come from vendors and users, not trials, and are not established. Because there is essentially no independent research on this specific analog, its safety profile, toxicity, drug interactions, contraindications, and use in pregnancy are entirely not characterised — absence of reported harm here reflects absence of study, not evidence of safety. Identity and purity of material sold under this name cannot be assumed.